Catch Up on Prenatal and Neonatal Testing Technologies and Industry Moves with Kalorama’s Clinical OMICs Article

Catch Up on Prenatal and Neonatal Testing Technologies and Industry Moves with Kalorama’s Clinical OMICs Article

Kalorama Information provides comprehensive insights into the prenatal and neonatal testing markets and industry withThe Market for Prenatal, Newborn and Carrier Genetic Testing. Read more regarding the market with Kalorama’s article in Clinical OMICs - Prenatal Testing Upgraded with Sequencing, Microarrays and Mass Spec.

The prenatal testing market has become, technologically speaking, quite diverse in less than 10 years. Industry stalwart PerkinElmer serves as an effective case study as it has made a string of acquisitions aimed at keeping pace with an industry moving towards non-invasive prenatal testing (NIPT) using molecular technologies. Several molecular NIPT companies have achieved significant market growth in recent years, utilizing microarray and next-generation sequencing (NGS) technologies as lab services, out-licensing opportunities and platforms for the development of test kits.